Your browser doesn't support javascript.
loading
¿Hay que añadir un cuarto fármaco a la pauta actual de tratamiento de la tuberculosis inicial? / Is it necessary to add a fourth drug to the initial treatment of tuberculosis?
Martín Casabona, Nuria; Caylà, Josep Antoni.
Affiliation
  • Martín Casabona, Nuria; Ciutat Sanitaria Universitari Vall d´Hebron. Barcelona. España
  • Caylà, Josep Antoni; Institut Municipal de Salut Públcia. Barcelona. España
Med. clín (Ed. impr.) ; 116(16): 638-638, mayo 2001.
Article in Es | IBECS | ID: ibc-12467
Responsible library: ES1.1
Localization: ES1.1 - BNCS
RESUMEN
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Health context: Neglected Diseases Health problem: Neglected Diseases / Tuberculosis Database: IBECS Main subject: Spain / Tuberculosis, Multidrug-Resistant / Antitubercular Agents Limits: Humans Country/Region as subject: Europa Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2001 Document type: Article Institution/Affiliation country: Ciutat Sanitaria Universitari Vall d´Hebron/España / Institut Municipal de Salut Públcia/España
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Health context: Neglected Diseases Health problem: Neglected Diseases / Tuberculosis Database: IBECS Main subject: Spain / Tuberculosis, Multidrug-Resistant / Antitubercular Agents Limits: Humans Country/Region as subject: Europa Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2001 Document type: Article Institution/Affiliation country: Ciutat Sanitaria Universitari Vall d´Hebron/España / Institut Municipal de Salut Públcia/España